Ahmed Abouabdellah

This inventor holds 23 USPTO granted patents and 5 published patent applications and 11 EPO patents, primarily in Carbamate Derivatives. Top assignees: Sanofi-Aventis, Sanofi. Active years: 2006-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ahmed Abouabdellah. Retrieved from https://idiyas.com/inventor/ahmed-abouabdellah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 5)

% Patents Active = 17.4

EPO Patents = 11 (Patent Applications = 8)

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 47(Granted Patents)

Location History:

Thiais, FR (2006 - 2011)
Vigneux, FR (2012)
Paris, FR (2013 - 2015)

Company Filing History:

Years Active: 2006-2015

Loading Chart...

Areas of Expertise:

Carbamate Derivatives

Therapeutic Applications

Alkyl-Heterocycles

5-Membered Compounds

Piperazine Derivatives

Dioxane Derivatives

FAAH Inhibitors

Cyclopenta Compounds

Heteroaryl Compounds

Arylalkyl Derivatives

Piperidinyl Derivatives

Synthesis Methods

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9000010 - Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application (2015-04-07),

2. 8912218 - Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof (2014-12-16),

3. 8889702 - Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof (2014-11-18),

4. 8865738 - 5-membered heterocyclic compound cyclopenta[C]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof (2014-10-21),

5. 8716289 - Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof (2014-05-06),

6. 8697883 - Cyclopenta[C]pyrrole-2-carboxylate derivatives, preparation thereof and therapeutic use thereof (2014-04-15),

7. 8394787 - 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof (2013-03-12),

8. 8119687 - Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics (2012-02-21),

9. 8114866 - Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme (2012-02-14),

10. 8034818 - Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates (2011-10-11),

11. 8026258 - Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics (2011-09-27),

12. 7973042 - Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors (2011-07-05),

13. 7781590 - Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors (2010-08-24),

14. 7777057 - Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics (2010-08-17),

15. 7696374 - Arylalklcarbamate derivatives, preparation method thereof and use of same in therapeutics (2010-04-13),

Certainly! Here is the article about the inventor Ahmed Abouabdellah:

Title: Ahmed Abouabdellah: A Trailblazer in Inventions

Introduction

Ahmed Abouabdellah is a distinguished inventor based in Thiais, France, who has left a significant mark in the realm of innovation. With a portfolio boasting 23 patents, his work has been pivotal in advancing various fields, particularly in the domain of pharmaceuticals.

Latest Patents

Ahmed's latest patents encompass groundbreaking discoveries:

1. Alkyl-heterocycle carbamate derivatives: This invention focuses on compounds crucial in therapeutic applications.

2. Alkylthiazol carbamate derivatives: These novel products hold potential as MET inhibitors, opening new possibilities in medicine.

Career Highlights

Having worked with renowned companies like Sanofi and Sanofi-Aventis, Ahmed has not only showcased his inventive prowess but also contributed to the growth of the pharmaceutical industry. His patents reflect his commitment to developing innovative solutions that have a tangible impact on society.

Collaborations

During his illustrious career, Ahmed has collaborated with notable professionals such as Christian Hoornaert and Antonio Almario Garcia. These partnerships have led to synergistic efforts, resulting in the creation of pioneering inventions that have garnered attention on a global scale.

Conclusion

In conclusion, Ahmed Abouabdellah stands out as a true luminary in the world of inventions, consistently pushing boundaries and shaping the future of technology. His relentless passion for innovation and unwavering dedication to creating positive change continue to inspire inventors and entrepreneurs worldwide, leaving an indelible legacy in the realm of inventions.

Profile summary based on public USPTO records.